Telix Total Assets from 2010 to 2024

TLX Stock

14.77 0.23 1.53%

Telix Pharmaceuticals Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets will likely drop to about 253.4 M in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2010-12-31

Previous Quarter

398.3 M

Current Value

253.4 M

Quarterly Volatility

70.1 M

Credit Downgrade

Yuan Drop

Covid

Check Telix Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Telix Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.1 M, Interest Expense of 7.1 M or Selling General Administrative of 57.5 M, as well as many indicators such as Price To Sales Ratio of 0.41, Days Sales Outstanding of 45.23 or Invested Capital of 0.0. Telix financial statements analysis is a perfect complement when working with Telix Pharmaceuticals Valuation or Volatility modules.

Check out the analysis of Telix Pharmaceuticals Correlation against competitors.

Latest Telix Pharmaceuticals' Total Assets Growth Pattern

Below is the plot of the Total Assets of Telix Pharmaceuticals Limited over the last few years. Total assets refers to the total amount of Telix Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Telix Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Telix Pharmaceuticals' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Telix Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 398.3 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Telix Total Assets Regression Statistics

	Arithmetic Mean	183,523,565
	Geometric Mean	174,623,719
	Coefficient Of Variation	38.22
	Mean Deviation	47,525,171
	Median	157,821,000
	Standard Deviation	70,135,424
	Sample Variance	4919T
	Range	288.5M
	R-Value	0.55
	Mean Square Error	3705.4T
	R-Squared	0.30
	Significance	0.03
	Slope	8,597,315
	Total Sum of Squares	68865.7T

Telix Total Assets History

	2024	253.4 M
	2023	398.3 M
	2022	255.4 M
	2021	109.8 M

Other Fundumenentals of Telix Pharmaceuticals

Intangibles To Total Assets

Telix Pharmaceuticals Total Assets component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock
Total Assets		0.78	0.87	-0.74	-0.78	0.93	0.95	0.73	0.94	0.98	0.87	0.91	0.95
Total Stockholder Equity	0.78		0.47	-0.82	-0.25	0.5	0.55	0.37	0.51	0.79	0.78	0.73	0.58
Current Deferred Revenue	0.87	0.47		-0.64	-0.94	0.92	0.93	0.82	0.93	0.84	0.71	0.8	0.92
Net Debt	-0.74	-0.82	-0.64		0.5	-0.49	-0.57	-0.74	-0.57	-0.82	-0.52	-0.53	-0.68
Retained Earnings	-0.78	-0.25	-0.94	0.5		-0.89	-0.9	-0.9	-0.92	-0.77	-0.49	-0.62	-0.92
Accounts Payable	0.93	0.5	0.92	-0.49	-0.89		0.99	0.7	0.99	0.87	0.81	0.89	0.95
Net Receivables	0.95	0.55	0.93	-0.57	-0.9	0.99		0.77	1.0	0.92	0.79	0.87	0.98
Good Will	0.73	0.37	0.82	-0.74	-0.9	0.7	0.77		0.8	0.81	0.32	0.44	0.87
Total Liab	0.94	0.51	0.93	-0.57	-0.92	0.99	1.0	0.8		0.91	0.75	0.84	0.98
Total Current Assets	0.98	0.79	0.84	-0.82	-0.77	0.87	0.92	0.81	0.91		0.77	0.82	0.95
Short Term Debt	0.87	0.78	0.71	-0.52	-0.49	0.81	0.79	0.32	0.75	0.77		0.99	0.71
Intangible Assets	0.91	0.73	0.8	-0.53	-0.62	0.89	0.87	0.44	0.84	0.82	0.99		0.79
Common Stock	0.95	0.58	0.92	-0.68	-0.92	0.95	0.98	0.87	0.98	0.95	0.71	0.79

Click cells to compare fundamentals

About Telix Pharmaceuticals Financial Statements

Telix Pharmaceuticals investors use historical fundamental indicators, such as Telix Pharmaceuticals' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Telix Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	398.3 M	253.4 M
Intangibles To Total Assets	0.28	0.29

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Telix Stock Analysis

When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC